The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-κB ligand–stimulated induction of nuclear factor of activated T cells c1
Makoto Urushibara, Hiroshi Takayanagi, Takako Koga, Sunhwa Kim, Miho Isobe, Yasuyuki Morishita, Takumi Nakagawa, Monika Löeffler, Tatsuhiko Kodama, Hisashi Kurosawa, Tadatsugu TaniguchiVolume:
50
Year:
2004
Language:
english
Pages:
11
DOI:
10.1002/art.20206
File:
PDF, 281 KB
english, 2004